Armour CR, Sovacool KL, Close WL, Topcuoglu BD, Wiens J, Schloss PD.
2023.
Preprint: Machine learning classification by fitting amplicon sequences to existing OTUs.
Armour CR, Topcuoglu BD, Garretto A, Schloss PD.
2022.
A Goldilocks Principle for the Gut Microbiome: Taxonomic Resolution Matters for Microbiome-Based Classification of Colorectal Cancer.
mBio.
13:
e03161-21.
DOI: 10.1128/mbio.03161-21.
Topçuoğlu BD, Lesniak NA, Ruffin MT IV, Wiens J, Schloss PD.
2020.
Effective application of machine learning to microbiome-based classification problems.
mBio.
11:
1-13.
DOI: 10.1128/mBio.00434-20.
Yu AI, Zhao L, Eaton KA, Ho S, Chen J, Poe S, Becker J, Gonzalez A, McKinstry D, Hasso M, Mendoza-Castrejon J, Whitfield J, Koumpouras C, Schloss PD, Martens EC, and Chen GY.
2020.
Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis.
Cell Reports.
31:
107471.
DOI: 10.1016/j.celrep.2020.03.035.
Sze MA, Topçuoğlu BD, Lesniak NA, IV Ruffin MT, Schloss PD.
2019.
Fecal short-chain fatty acids are not predictive of colonic tumor status and cannot be predicted based on bacterial community structure.
mBio.
10:
e01454-19.
DOI: 10.1128/mBio.01454-19.
Flynn KJ, Ruffin MT IV, Turgeon DK, Schloss PD.
2018.
Spatial variation of the native colon microbiota in healthy adults.
Cancer Prev Res (Phila).
11:
393-401.
DOI: 10.1158/1940-6207.CAPR-17-0370.
Hannigan GD, Duhaime MB, Ruffin IV MT, Koumpouras CC, Schloss PD.
2018.
The Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome.
mBio.
9:
e02248-18.
DOI: 10.1128/mBio.02248-18.
Sze MA, Schloss PD.
2018.
Leveraging Existing 16S rRNA Gene Surveys to Identify Reproducible Biomarkers in Individuals with Colorectal Tumors.
mBio.
9:
e00630-18.
DOI: 10.1128/mBio.00630-18.
Seregin SS, Golovchenko N, Schaf B, Chen J, Pudlo NA, Mitchell J, Baxter NT, Zhao L, Schloss PD, Martens EC, Eaton KA, Chen GY.
2017.
NLRP6 protects IL10-/- mice from colitis by limiting colonization of Akkermansia muciniphila.
Cell Reports.
19:
733-745.
DOI: 10.1016/j.celrep.2017.03.080.
Sze MA, Baxter NT, Ruffin MT IV, Rogers MAM, Schloss PD.
2017.
Normalization of the microbiota in patients after treatment for colonic lesions.
Microbiome.
5:
150.
DOI: 10.1186/s40168-017-0366-3.
Baxter NT, Ruffin MT 4th, Rogers MA, Schloss PD.
2016.
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.
Genome Medicine.
8:
1.
DOI: 10.1186/s13073-016-0290-3.
Baxter NT, Koumpouras CC, Rogers MA, Ruffin MT 4th, Schloss PD.
2016.
DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
Microbiome.
4:
59.
DOI: 10.1186/s40168-016-0205-y.
Flynn KJ, Baxter NT, Schloss PD.
2016.
Metabolic and community synergy of oral bacteria in colorectal cancer.
mSphere.
1:
e00102-16.
DOI: 10.1128/mSphere.00102-16.
Zackular JP, Baxter NT, Chen GH, Schloss PD.
2015.
Manipulation of the gut microbiota reveals role in colon tumorigenesis.
mSphere.
1:
e00001-e00015.
DOI: 10.1128/mSphere.00001-15.
Baxter NT, Zackular JP, Chen GY, Schloss PD.
2014.
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden.
Microbiome.
2:
20.
DOI: 10.1186/2049-2618-2-20.
Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD.
2014.
The human gut microbiome as a screening tool for colorectal cancer.
Cancer Prev Res (Phila).
7:
1112-21.
DOI: 10.1158/1940-6207.CAPR-14-0129.
Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, Schloss PD.
2013.
The gut microbiome modulates colon tumorigenesis.
mBio.
4:
e00692-13.
DOI: 10.1128/mBio.00692-13.